Entourage Health Corp. (ENTG.V)

CAD 0.01

(0.0%)

Long Term Debt Summary of Entourage Health Corp.

Entourage Health Corp.'s latest annual long term debt in 2023 was 5.79 Million CAD , down -0.58% from previous year.
Entourage Health Corp.'s latest quarterly long term debt in 2024 Q2 was 6.14 Million CAD , up 3.2% from previous quarter.
Entourage Health Corp. reported annual long term debt of 5.82 Million CAD in 2022, down -9.03% from previous year.
Entourage Health Corp. reported annual long term debt of 6.4 Million CAD in 2021, down -91.52% from previous year.
Entourage Health Corp. reported quarterly long term debt of 6.14 Million CAD for 2024 Q2, up 3.2% from previous quarter.
Entourage Health Corp. reported quarterly long term debt of 5.79 Million CAD for 2023 Q4, down -7.08% from previous quarter.

Annual Long Term Debt Chart of Entourage Health Corp. (2023 - 2014)

Historical Annual Long Term Debt of Entourage Health Corp. (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	5.79 Million CAD	-0.58%
2022	5.82 Million CAD	-9.03%
2021	6.4 Million CAD	-91.52%
2020	75.5 Million CAD	69.82%
2019	44.46 Million CAD	0.0%
2018	- CAD	-100.0%
2017	11.35 Million CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	5.95 Million CAD	2.81%
2024 Q2	6.14 Million CAD	3.2%
2023 Q4	5.79 Million CAD	-7.08%
2023 FY	5.79 Million CAD	-0.58%
2023 Q1	5.95 Million CAD	2.18%
2023 Q2	6.09 Million CAD	2.35%
2023 Q3	6.23 Million CAD	2.3%
2022 Q2	113.71 Million CAD	1678.22%
2022 Q4	5.82 Million CAD	-95.03%
2022 FY	5.82 Million CAD	-9.03%
2022 Q1	6.39 Million CAD	-0.16%
2022 Q3	117.22 Million CAD	3.09%
2021 Q3	1.01 Million CAD	-97.77%
2021 FY	6.4 Million CAD	-91.52%
2021 Q1	71.3 Million CAD	-5.56%
2021 Q2	45.4 Million CAD	-36.33%
2021 Q4	6.4 Million CAD	531.93%
2020 Q4	75.5 Million CAD	0.59%
2020 FY	75.5 Million CAD	69.82%
2020 Q3	75.06 Million CAD	67.93%
2020 Q2	44.7 Million CAD	0.66%
2020 Q1	44.4 Million CAD	-0.13%
2019 Q3	43.32 Million CAD	19.54%
2019 FY	44.46 Million CAD	0.0%
2019 Q4	44.46 Million CAD	2.63%
2019 Q1	35.43 Million CAD	0.0%
2019 Q2	36.24 Million CAD	2.29%
2018 Q4	- CAD	-100.0%
2018 FY	- CAD	-100.0%
2018 Q3	2.36 Million CAD	3.8%
2018 Q1	8.61 Million CAD	-24.07%
2018 Q2	2.27 Million CAD	-73.61%
2017 Q1	- CAD	-100.0%
2017 Q2	- CAD	0.0%
2017 Q3	- CAD	0.0%
2017 Q4	11.35 Million CAD	0.0%
2017 FY	11.35 Million CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q4	6.39 Million CAD	0.0%
2016 Q2	- CAD	0.0%
2016 Q1	- CAD	0.0%
2016 Q3	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 FY	- CAD	0.0%
2015 Q2	- CAD	0.0%
2015 Q1	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q3	- CAD	0.0%

Peer Long Term Debt Comparison of Entourage Health Corp.

Name	Long Term Debt	Long Term Debt Difference
Aequus Pharmaceuticals Inc.	583.58 Thousand CAD	-892.665%
CanadaBis Capital Inc.	5.91 Million CAD	2.084%
Decibel Cannabis Company Inc.	32.34 Million CAD	82.091%
Delivra Health Brands Inc.	1.78 Million CAD	-224.541%
Lifeist Wellness Inc.	868.65 Thousand CAD	-566.898%
Cannara Biotech Inc.	39.73 Million CAD	85.422%
Medicure Inc.	229 Thousand CAD	-2429.718%
PharmaCielo Ltd.	2.55 Million CAD	-126.875%
Rubicon Organics Inc.	- CAD	-Infinity%
BioSyent Inc.	1.03 Million CAD	-458.242%
Voyageur Pharmaceuticals Ltd.	40 Thousand CAD	-14382.638%